Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 2
2008 4
2009 1
2010 1
2011 1
2012 4
2013 2
2014 2
2015 2
2016 1
2021 2
2022 4
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Observational 6-month open-label study of Japanese type 2 diabetes patients switching from NPH insulin to insulin detemir in basal-bolus regimen: 23rd article of the Japan Diabetes Clinical Data Management Study Group (JDDM23).
Oishi M, Abe N, Yokoyama H, Kuribayashi N, Tomonaga O, Matoba K, Kobayashi M; Japan Diabetes Clinical Data Management Study Group. Oishi M, et al. J Int Med Res. 2012;40(2):787-97. doi: 10.1177/147323001204000245. J Int Med Res. 2012. PMID: 22613444 Free article.
Clinical course of different long-acting insulin therapies-glargine U100, U300, degludec, and insulin degludec/insulin aspart-among Japanese patients with type 2 diabetes: a multicenter retrospective observational study (JDDM65 study).
Iwamoto M, Nakanishi S, Iwamoto H, Kaneto H, Maegawa H; Japan Diabetes Clinical Data Management Study Group (JDDM study group). Iwamoto M, et al. Endocr J. 2022 Jul 28;69(7):763-771. doi: 10.1507/endocrj.EJ21-0647. Epub 2022 Jan 26. Endocr J. 2022. PMID: 35082188 Free article.
Actual usage and clinical effectiveness of insulin preparations in patients with Type 1 diabetes mellitus in Japan: CoDiC-based analysis of clinical data obtained at multiple institutions (JDDM 3).
Kanatsuka A, Kawai K, Hirao K, Oishi M, Takagi H, Kobayashi M; Japan Diabetes Clinical Data Management Study Group. Kanatsuka A, et al. Diabetes Res Clin Pract. 2006 Jun;72(3):277-83. doi: 10.1016/j.diabres.2005.03.040. Epub 2006 Apr 17. Diabetes Res Clin Pract. 2006. PMID: 16616794
Current status of oral antidiabetic drug prescribing patterns based on the body mass index for Japanese type 2 diabetes mellitus patients and yearly changes in diabetologists' prescribing patterns from 2002 to 2019 (JDDM61).
Yagi N, Komiya I, Arai K, Oishi M, Fukumoto Y, Shirabe S, Yokoyama H, Yamazaki K, Sugimoto H, Maegawa H; Japan Diabetes Clinical Data Management Study Group (JDDM study group),. Yagi N, et al. J Diabetes Investig. 2022 Jan;13(1):65-73. doi: 10.1111/jdi.13621. Epub 2021 Jul 30. J Diabetes Investig. 2022. PMID: 34191401 Free PMC article.
The renoprotective effect of once-weekly GLP-1 receptor agonist dulaglutide on progression of nephropathy in Japanese patients with type 2 diabetes and moderate to severe chronic kidney disease (JDDM67).
Tsuchida KI, Taneda S, Yokota I, Okada K, Kurihara Y, Yokoyama H, Iwamoto M, Yamazaki K, Ishigaki Y, Manda N, Maegawa H; Japan Diabetes Clinical Data Management Study Group (JDDM study group). Tsuchida KI, et al. J Diabetes Investig. 2022 Nov;13(11):1834-1841. doi: 10.1111/jdi.13877. Epub 2022 Jul 5. J Diabetes Investig. 2022. PMID: 35735780 Free PMC article.
21 results